Hey everyone! Hope you’re all staying safe and healthy out there.
Check out my latest YouTube video here. In this episode, I discuss key differences between two potential SMA treatments. The first is Roche and Genentech’s experimental therapy risdiplam, and the second is Scholar Rock’s therapy SRK-015. Both are hot topics in the SMA community right now.
We expect the FDA to make a decision regarding risdiplam later this year. My video also addresses this subject.
NOTE: Please visit our main website for more stories and information about these two therapies. You can find articles about risdiplam here, and articles about SRK-015 here. Thanks everyone! Hope you all enjoy this episode.
Do you have any additional questions about either of these treatments? Have you discussed them with your healthcare providers?
I’ve had my eye on Scholar Rock for a long time. I really do believe that their treatment paired with either Spinraza or risdiplam is going to be a game-changer for adults with SMA. Super eager to get more information on this one!
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.